US Patent Issued to QURIENT, LEAD DISCOVERY CENTER on April 21 for "Substituted pyrazolo[1,5-a[1,3,5triazines as CDK inhibitors" (South Korean, German Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,561, issued on April 21, was assigned to QURIENT Co. LTD. (Gyeonggi-do, South Korea) and LEAD DISCOVERY CENTER GMBH (Dortmund, Germany).

"Substituted pyrazolo[1,5-a[1,3,5triazines as CDK inhibitors" was invented by Kiyean Nam (Gyeonggi-Do, South Korea), Jaeseung Kim (Seoul, South Korea), Yeejin Jeon (Gyeonggi-Do, South Korea), Donghoon Yu (Gyeonggi-Do, South Korea), Mooyoung Seo (Gyeonggi-Do, South Korea), Dongsik Park (Gyeonggi-Do, South Korea), Jan Eickhoff (Herdecke, Germany), Gunther Zischinsky (Dortmund, Germany) and Uwe Koch (Dortmund, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to pyrazolo[1,5-a][1,3,...